OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
55 hedge funds and large institutions have $200M invested in OncoMed Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
–
Holders Change %
0%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
25
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CLOS
51
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $50K | – | – | – |
|
52
AllianceBernstein
Nashville,
Tennessee
| $50K | +$47.5K | +1,400 | +1,918% |
|
|
PCM
53
Prelude Capital Management
New York
| $37K | +$37K | +1,100 | New |
|
54
Wells Fargo
San Francisco,
California
| $15K | +$4.96K | +150 | +49% |
|
55
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $145 | +$139 | +4,132 | +2,334% |
|
|
EMG
56
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$440K | -14,900 | Closed |
|
57
Two Sigma Investments
New York
| – | -$300K | -10,172 | Closed |
|
58
Citadel Advisors
Miami,
Florida
| – | -$264K | -8,953 | Closed |
|
|
BJ
59
BlackRock Japan
Tokyo,
Japan
| – | -$159K | -5,393 | Closed |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | -$121K | -4,102 | Closed |
|
|
SO
61
STRS Ohio
Columbus,
Ohio
| – | -$56K | -1,900 | Closed |
|
|
QT
62
Quantbot Technologies
New York
| – | -$41K | -1,400 | Closed |
|
|
WEC
63
Winslow Evans & Crocker
Boston,
Massachusetts
| – | -$3K | -95 | Closed |
|